Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 302

1.

Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issues.

Rutten-van Mölken MP, Goossens LM.

Pharmacoeconomics. 2012 Apr;30(4):271-302. doi: 10.2165/11589270-000000000-00000. Review.

PMID:
22409290
2.
3.

Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.

Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, Muers M, Smith D, White J.

Health Technol Assess. 2001;5(26):1-149. Review.

4.

Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries.

Oostenbrink JB, Rutten-van Mölken MP, Monz BU, FitzGerald JM.

Value Health. 2005 Jan-Feb;8(1):32-46.

6.

Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.

Ohar JA, Donohue JF.

Semin Respir Crit Care Med. 2010 Jun;31(3):321-33. doi: 10.1055/s-0030-1254072. Epub 2010 May 21. Review.

PMID:
20496301
7.

Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.

Dalal AA, Roberts MH, Petersen HV, Blanchette CM, Mapel DW.

Int J Chron Obstruct Pulmon Dis. 2010 Dec 31;6:13-22. doi: 10.2147/COPD.S15455.

8.

Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.

Chen AM, Bollmeier SG, Finnegan PM.

Ann Pharmacother. 2008 Dec;42(12):1832-42. doi: 10.1345/aph.1L250. Epub 2008 Oct 28. Review.

PMID:
18957624
9.

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.

Ann Intern Med. 2007 Apr 17;146(8):545-55. Epub 2007 Feb 19.

PMID:
17310045
10.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
11.

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.

Asche CV, Leader S, Plauschinat C, Raparla S, Yan M, Ye X, Young D.

Int J Chron Obstruct Pulmon Dis. 2012;7:201-9. doi: 10.2147/COPD.S25805. Epub 2012 Mar 15.

12.

Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.

Sobieraj DM, White CM, Coleman CI.

Clin Ther. 2008 Aug;30(8):1416-25. doi: 10.1016/j.clinthera.2008.08.004.

PMID:
18803985
13.

Cost-effectiveness analysis of roflumilast/tiotropium therapy versus tiotropium monotherapy for treating severe-to-very severe COPD.

Sun SX, Marynchenko M, Banerjee R, Cheng D, Mocarski M, Yin D, Yu AP, Wu EQ.

J Med Econ. 2011;14(6):805-15. doi: 10.3111/13696998.2011.623204. Epub 2011 Oct 12.

PMID:
21992217
14.
15.
16.

Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD.

Najafzadeh M, Marra CA, Sadatsafavi M, Aaron SD, Sullivan SD, Vandemheen KL, Jones PW, Fitzgerald JM.

Thorax. 2008 Nov;63(11):962-7. doi: 10.1136/thx.2007.089557. Epub 2008 Jul 11.

PMID:
18621985
17.
18.

Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.

Breekveldt-Postma NS, Koerselman J, Erkens JA, Lammers JW, Herings RM.

Respir Med. 2007 Jul;101(7):1398-405. Epub 2007 Mar 23.

19.

Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.

Baker WL, Baker EL, Coleman CI.

Pharmacotherapy. 2009 Aug;29(8):891-905. doi: 10.1592/phco.29.8.891.

PMID:
19637942
20.

Cost-utility analysis of indacaterol in Germany: a once-daily maintenance bronchodilator for patients with COPD.

Price D, Gray A, Gale R, Asukai Y, Mungapen L, Lloyd A, Peters L, Neidhardt K, Gantner T.

Respir Med. 2011 Nov;105(11):1635-47. doi: 10.1016/j.rmed.2011.06.005. Epub 2011 Jul 20.

Supplemental Content

Support Center